| Primary |
| Drug Use For Unknown Indication |
17.1% |
| Angina Pectoris |
15.8% |
| Arteriospasm Coronary |
10.5% |
| Product Used For Unknown Indication |
7.9% |
| Hypertension |
6.6% |
| Chest Pain |
5.3% |
| Coronary Artery Disease |
5.3% |
| Cardiac Disorder |
3.9% |
| Cardiac Failure Congestive |
3.9% |
| Diagnostic Procedure |
3.9% |
| Myocardial Ischaemia |
3.9% |
| Anal Fissure |
2.6% |
| Prinzmetal Angina |
2.6% |
| Sciatica |
2.6% |
| Acute Coronary Syndrome |
1.3% |
| Atrial Fibrillation |
1.3% |
| Atrioventricular Block |
1.3% |
| Benign Prostatic Hyperplasia |
1.3% |
| Cardiac Failure Acute |
1.3% |
| Epilepsy |
1.3% |
|
| Silent Myocardial Infarction |
22.2% |
| Myocardial Ischaemia |
16.0% |
| Product Quality Issue |
8.6% |
| Haemolytic Anaemia |
6.2% |
| Vomiting |
6.2% |
| Medication Error |
4.9% |
| Paradoxical Drug Reaction |
4.9% |
| Suicide Attempt |
4.9% |
| Syncope |
4.9% |
| Anaemia Haemolytic Autoimmune |
3.7% |
| Blood Pressure Decreased |
3.7% |
| Hypotension |
2.5% |
| Therapeutic Response Unexpected With Drug Substitution |
2.5% |
| Anaphylactic Shock |
1.2% |
| Angina Pectoris |
1.2% |
| Blood Potassium Decreased |
1.2% |
| Chest Pain |
1.2% |
| Cognitive Disorder |
1.2% |
| Dizziness |
1.2% |
| Drug Ineffective |
1.2% |
|
| Secondary |
| Product Used For Unknown Indication |
27.5% |
| Hypertension |
16.7% |
| Angina Pectoris |
11.5% |
| Cardiac Failure |
5.8% |
| Suicide Attempt |
5.2% |
| Hyperlipidaemia |
3.6% |
| Type 2 Diabetes Mellitus |
3.4% |
| Drug Use For Unknown Indication |
3.2% |
| Coronary Artery Disease |
3.1% |
| Diabetes Mellitus |
2.6% |
| Myocardial Ischaemia |
2.6% |
| Pain |
2.6% |
| Acute Coronary Syndrome |
2.3% |
| Myocardial Infarction |
1.9% |
| Atrial Fibrillation |
1.4% |
| Overdose |
1.4% |
| Prophylaxis |
1.4% |
| Premedication |
1.3% |
| Sleep Disorder |
1.3% |
| Schizophrenia |
1.2% |
|
| Suicide Attempt |
14.4% |
| Syncope |
13.6% |
| Angina Pectoris |
12.8% |
| Loss Of Consciousness |
8.8% |
| Completed Suicide |
4.8% |
| Hypotension |
4.8% |
| Fall |
4.0% |
| Myocardial Infarction |
4.0% |
| Thrombocytopenia |
4.0% |
| Cutaneous Lupus Erythematosus |
3.2% |
| Dizziness |
3.2% |
| Pancytopenia |
3.2% |
| Shock |
3.2% |
| Vomiting |
3.2% |
| Drug Interaction |
2.4% |
| Pain In Extremity |
2.4% |
| Vertigo |
2.4% |
| White Blood Cell Count Increased |
2.4% |
| Anaphylactic Shock |
1.6% |
| Arthralgia |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.4% |
| Drug Use For Unknown Indication |
19.9% |
| Hypertension |
10.7% |
| Angina Pectoris |
4.2% |
| Diabetes Mellitus |
3.1% |
| Cardiac Disorder |
2.9% |
| Coronary Artery Disease |
2.6% |
| Pain |
2.5% |
| Prophylaxis |
2.4% |
| Atrial Fibrillation |
2.3% |
| Rheumatoid Arthritis |
2.1% |
| Type 2 Diabetes Mellitus |
2.0% |
| Cardiac Failure |
2.0% |
| Blood Cholesterol Increased |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Osteoporosis |
1.8% |
| Multiple Myeloma |
1.5% |
| Constipation |
1.3% |
| Depression |
1.3% |
| Insomnia |
1.3% |
|
| Vomiting |
12.8% |
| Myocardial Infarction |
8.4% |
| Weight Decreased |
6.8% |
| Death |
6.1% |
| Pneumonia |
6.1% |
| Dyspnoea |
5.7% |
| Weight Increased |
5.7% |
| Rash |
5.2% |
| Renal Failure Acute |
4.8% |
| Pain |
4.1% |
| Pruritus |
4.0% |
| Thrombocytopenia |
3.9% |
| Vision Blurred |
3.8% |
| Renal Failure |
3.6% |
| Drug Ineffective |
3.4% |
| Hypotension |
3.3% |
| Flushing |
3.1% |
| Nausea |
3.1% |
| Rhabdomyolysis |
3.1% |
| Chest Pain |
3.0% |
|
| Interacting |
| Dementia |
44.9% |
| Hypertension |
30.6% |
| Coronary Artery Disease |
12.2% |
| Hyperlipidaemia |
6.1% |
| Type 2 Diabetes Mellitus |
6.1% |
|
| Syncope |
37.5% |
| Hypertension |
25.0% |
| Death |
12.5% |
| Drug Interaction |
12.5% |
| Somnolence |
12.5% |
|
